Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GARY V BURTON

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1316968761
CMS profile
486527
Location
SHREVEPORT, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$1,938.98

97 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,938.98 97

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GARY V BURTON

NPI 1316968761 · CMS profile ID 486527

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

SHREVEPORT, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1316968761?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GARY V BURTON, NPI 1316968761, CMS profile ID 486527. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1316968761?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). GARY V BURTON, NPI 1316968761, CMS profile ID 486527. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1316968761?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
GARY V BURTON, NPI 1316968761, CMS profile ID 486527, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1316968761?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

97 matching records · $1,938.98 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 97 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–97 of 97.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $23.1107/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050069675 CMS
Novartis Pharmaceuticals Corporation $23.6407/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805381 CMS
Regeneron Healthcare Solutions, Inc. $19.5207/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999109433 CMS
Novartis Pharmaceuticals Corporation $31.3507/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805377 CMS
Stemline Therapeutics Inc. $17.9307/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040026341 CMS
Daiichi Sankyo Inc. $24.2807/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006413561 CMS
AstraZeneca Pharmaceuticals LP $21.5907/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015353923 CMS
Eisai Inc. $14.7306/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023310965 CMS
AstraZeneca Pharmaceuticals LP $17.7206/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011274523 CMS
Gilead Sciences, Inc. $20.0506/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025814503 CMS
Pharmacyclics LLC, An AbbVie Company $22.7606/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998282791 CMS
Seagen Inc. $13.2406/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995696063 CMS
Gilead Sciences, Inc. $23.2306/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025700797 CMS
Daiichi Sankyo Inc. $29.4906/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006448201 CMS
Janssen Biotech, Inc. $24.6706/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988181485 CMS
Janssen Biotech, Inc. $0.9406/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988181475 CMS
Kite Pharma, Inc. $14.6605/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025267695 CMS
Karyopharm Therapeutics Inc. $21.1605/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056900435 CMS
BeiGene USA, Inc. $17.1505/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051181257 CMS
E.R. Squibb & Sons, L.L.C. $41.7605/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015774247 CMS
Astellas Pharma US Inc $23.8005/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034090229 CMS
Novartis Pharmaceuticals Corporation $22.9305/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805325 CMS
AstraZeneca Pharmaceuticals LP $14.7404/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015004467 CMS
Eli Lilly and Company $54.0204/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031426057 CMS
Seagen Inc. $13.0604/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995695991 CMS
Novartis Pharmaceuticals Corporation $25.8804/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805321 CMS
Regeneron Healthcare Solutions, Inc. $14.2104/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999109429 CMS
Daiichi Sankyo Inc. $25.8004/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006347575 CMS
Novartis Pharmaceuticals Corporation $21.6203/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805341 CMS
Stemline Therapeutics Inc. $20.2203/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040026331 CMS
E.R. Squibb & Sons, L.L.C. $18.0503/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015774239 CMS
Janssen Biotech, Inc. $21.2703/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988181465 CMS
Daiichi Sankyo Inc. $18.3003/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006360641 CMS
Novartis Pharmaceuticals Corporation $14.1603/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805309 CMS
Merck Sharp & Dohme LLC $17.6302/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048263243 CMS
E.R. Squibb & Sons, L.L.C. $18.1102/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015774185 CMS
Pharmacyclics LLC, An AbbVie Company $20.8602/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998282789 CMS
Celgene Corporation $15.1102/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015774179 CMS
Novartis Pharmaceuticals Corporation $23.8602/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805305 CMS
Merck Sharp & Dohme LLC $15.9501/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048263245 CMS
Seagen Inc. $14.6501/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995695857 CMS
Janssen Biotech, Inc. $12.8101/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988181455 CMS
E.R. Squibb & Sons, L.L.C. $15.5901/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015773953 CMS
AstraZeneca Pharmaceuticals LP $17.9301/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011882991 CMS
Celgene Corporation $13.2801/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015773949 CMS
AstraZeneca Pharmaceuticals LP $13.4301/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015198023 CMS
BeiGene USA, Inc. $18.0501/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051181255 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $309.04 18
PY2020 $162.87 10
PY2021 $114.40 7
PY2022 $794.52 48
PY2023 $1,938.98 97
PY2024 $3,064.02 111
PY2025 $3,313.07 122

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $235,114.26 4
PY2024 Principal investigator $103,440.40 8
PY2023 Principal investigator $91,467.77 8
PY2022 Principal investigator $12,951.85 6
PY2021 Principal investigator $4,321.37 3
PY2020 Principal investigator $960.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $99,793.16 12/31/2025 Non-covered Recipient Entity
Louisiana State University Health Sciences Shreveport
A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab MK-3475 Versus Treatment of Physician s Choice TPC in Participants With Triple-Negative Breast Cancer TNBC Who Received No dispute reported 06/30/2026 1232924088
Principal investigator 1 Merck Sharp & Dohme LLC $99,793.16 12/31/2025 Non-covered Recipient Entity
Ochsner LSU Health Monroe Medical Center, Family Medicine Clinic
A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab MK-3475 Versus Treatment of Physician s Choice TPC in Participants With Triple-Negative Breast Cancer TNBC Who Received No dispute reported 06/30/2026 1232924128
Principal investigator 1 Merck Sharp & Dohme LLC $34,277.94 12/31/2025 Non-covered Recipient Entity
Louisiana State University Health Sciences Shreveport
A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT Sacituzumab Tirumotecan, MK-2870 Followed by Carboplatin,Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Earl No dispute reported 06/30/2026 1232925399
Principal investigator 1 PFIZER INC. $1,250.00 05/01/2025 Non-covered Recipient Entity
LSU Health Sciences Center Shreveport General Fund
A PHASE 3 RANDOMIZED OPENLABEL MULTICENTER TRIAL OF ARV471 PF07850327 VS FULVESTRANT IN PARTICIPANTS WITH ESTROGEN RECEPTORPOSITIVE HER2NEGATIVE ADVANCED BREAST CANCER WHOSE DISEASE PROGRESSED AFTER PRIOR ENDOCRINE BASED TREATMENT FOR ADVANCED DISEASE VERITAC2 No dispute reported 06/30/2026 1228720763